Detalles de la búsqueda
1.
Circulating Cell-Free Tumour DNA in the Management of Cancer.
Int J Mol Sci
; 16(6): 14122-42, 2015 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26101870
2.
Differential subcellular and extracellular localisations of proteins required for insulin-like growth factor- and extracellular matrix-induced signalling events in breast cancer progression.
BMC Cancer
; 14: 627, 2014 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25167778
3.
A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
Int J Cancer
; 130(1): 71-82, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21384344
4.
Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.
Breast Cancer Res Treat
; 134(2): 617-24, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22678156
5.
Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events.
BMC Cancer
; 12: 132, 2012 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22471922
6.
High prevalence of human papillomaviruses in fresh frozen breast cancer samples.
J Med Virol
; 83(12): 2157-63, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22012724
7.
The Royal College of Pathologists of Australasia Quality Assurance Program: Immunohistochemistry Breast Marker Audit Overview 2005-2015.
Appl Immunohistochem Mol Morphol
; 27(5): 339-344, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-29189257
8.
Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.
Am J Surg Pathol
; 43(5): 695-702, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30720533
9.
HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.
Pathology
; 49(6): 575-581, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28823752
10.
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.
Appl Immunohistochem Mol Morphol
; 25(2): 79-85, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28182587
11.
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry.
Appl Immunohistochem Mol Morphol
; 25(4): 227-230, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27941560
12.
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers.
Appl Immunohistochem Mol Morphol
; 25(1): 4-11, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27922482
13.
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories.
Appl Immunohistochem Mol Morphol
; 25(3): 151-159, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28187030
14.
Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
Pathology
; 38(5): 391-8, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17008275
15.
Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.
Pathology
; 38(2): 120-4, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16581651
16.
Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program.
Pathology
; 48(6): 535-42, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27567228
17.
Metastatic de-differentiated melanoma resembling synovial sarcoma diagnosed by synchronous NRAS genetic mutation.
ANZ J Surg
; 90(11): 2378-2380, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32141640
18.
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.
Appl Immunohistochem Mol Morphol
; 23(1): 1-18, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25474126
19.
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.
Nat Commun
; 6: 5899, 2015 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25641231
20.
Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.
Appl Immunohistochem Mol Morphol
; 22(4): 241-52, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24714041